These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 26851125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y, He Y, Yang J, Han W, Zhai X, Zhao Y, Li Y.
    Int J Mol Sci; 2018 Feb 23; 19(2):. PubMed ID: 29473866
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design of novel dopamine D2 and serotonin 5-HT2A receptors dual antagonists toward schizophrenia: An integrated study with QSAR, molecular docking, virtual screening and molecular dynamics simulations.
    Zhang C, Li Q, Meng L, Ren Y.
    J Biomol Struct Dyn; 2020 Feb 23; 38(3):860-885. PubMed ID: 30916624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.
    Blagg J, Allerton CM, Batchelor DV, Baxter AD, Burring DJ, Carr CL, Cook AS, Nichols CL, Phipps J, Sanderson VG, Verrier H, Wong S.
    Bioorg Med Chem Lett; 2007 Dec 15; 17(24):6691-6. PubMed ID: 17976986
    [Abstract] [Full Text] [Related]

  • 14. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Varady J, Wu X, Fang X, Min J, Hu Z, Levant B, Wang S.
    J Med Chem; 2003 Oct 09; 46(21):4377-92. PubMed ID: 14521403
    [Abstract] [Full Text] [Related]

  • 15. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L, Feng R, Bi J, Shen S, Lu H, Zhang J.
    J Mol Model; 2018 Mar 06; 24(4):86. PubMed ID: 29511885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine D3 receptor agonists as pharmacological tools.
    Kassel S, Schwed JS, Stark H.
    Eur Neuropsychopharmacol; 2015 Sep 06; 25(9):1480-99. PubMed ID: 25498414
    [Abstract] [Full Text] [Related]

  • 18. 3D-QSAR and docking studies of 3-arylquinazolinethione derivatives as selective estrogen receptor modulators.
    Xiao A, Zhang Z, An L, Xiang Y.
    J Mol Model; 2008 Feb 06; 14(2):149-59. PubMed ID: 18172701
    [Abstract] [Full Text] [Related]

  • 19. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
    Khan N, Halim SA, Khan W, Zafar SK, Ul-Haq Z.
    J Mol Graph Model; 2019 Jun 06; 89():199-214. PubMed ID: 30908997
    [Abstract] [Full Text] [Related]

  • 20. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T, Srinivasan P.
    J Recept Signal Transduct Res; 2014 Aug 06; 34(4):241-53. PubMed ID: 25072161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.